Skip to main content

Zhiguo Li

Associate Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Biostatistics
Duke Box 2721, Durham, NC 27710
2424 Erwin Road Ste 1102, 11086 Hock Plaza, Durham, NC 27705

Overview


survival analysis, dynamic treatment regimes, clinical trials

Current Appointments & Affiliations


Associate Professor of Biostatistics & Bioinformatics · 2021 - Present Biostatistics & Bioinformatics, Division of Biostatistics, Biostatistics & Bioinformatics
Member of the Duke Cancer Institute · 2010 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Isavuconazonium or posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia.

Journal Article J Oncol Pharm Pract · April 2024 BACKGROUND: Invasive fungal infection (IFI) prophylaxis is recommended in patients with acute myeloid leukemia (AML) during induction chemotherapy. Posaconazole (POSA) is the recommended agent of choice; however, this medication can be associated with QTc ... Full text Link to item Cite

Comparison of differing dose levels of methotrexate for patients with primary central nervous system lymphoma.

Journal Article J Oncol Pharm Pract · April 2024 INTRODUCTION: It has long been established that high-dose methotrexate is an essential part of therapy for primary central nervous system lymphoma. When regimens utilizing high-dose methotrexate were first studied, a dose of 8 g/m2 was used. More recently, ... Full text Link to item Cite

Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.

Journal Article Blood Adv · February 13, 2024 Chronic graft-versus-host disease (cGVHD) is a debilitating, autoimmune-like syndrome that can occur after allogeneic hematopoietic stem cell transplantation. Constitutively activated B cells contribute to ongoing alloreactivity and autoreactivity in patie ... Full text Open Access Link to item Cite
View All Publications

Recent Grants


Promoting T cell recovery after radiation injury with long-acting interleukin 7

ResearchStatistician · Awarded by National Institutes of Health · 2024 - 2027

Racial and Ethnic Differences in the Real-World Clinical Outcomes of IDH1 and IDH2 Inhibitors in Acute Myeloid Leukemia

ResearchStatistician · Awarded by University of North Carolina - Chapel Hill · 2024 - 2026

View All Grants

Education, Training & Certifications


University of Michigan, Ann Arbor · 2008 Ph.D.